Alnylam Pharmaceuticals Inc (ALNY) Insider Trading
- $71,277,732.32
- $381,826,108.55
- Aug. 20, 2024
- Akshay Vaishnaw
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Jan. 22, 2013 | Director | 4,967 | $20.13 | Buy | $99,985.71 |
Insiders are both buying and selling Alnylam Pharmaceuticals Inc stock.
The insider traders at Alnylam Pharmaceuticals Inc are: John Maraganore, Akshay Vaishnaw, Yvonne Greenstreet, Laurie Keating, Barry E Greene, Paul Schimmel, Philip A Sharp, Michael Mason, Laurence Reid, Pushkal Garg, Dennis A Ausiello, Tolga Tanguler, Steven M Paul, Sanofi, Kevin P Starr, Jeffrey V Poulton, Michael W Bonney, Phillip A Sharp, David E I Pyott, Indrani Lall Franchini, Amy W Schulman, John Clarke, Kevin Joseph Fitzgerald, Kevin P. Starr, Marsha Fanucci, Philip A. Sharp, and David-Alexandre C Gros
The most active insider trader at Alnylam Pharmaceuticals Inc is John Maraganore with 23 trades.
John Maraganore has sold the most Alnylam Pharmaceuticals Inc stock with a total value of $118,340,674.92.
Sanofi has bought the most Alnylam Pharmaceuticals Inc stock with a total value of $89,326,528.48.
The most recent insider trade for Alnylam Pharmaceuticals Inc was on Aug. 20, 2024.
The single biggest insider buy for Alnylam Pharmaceuticals Inc was from Sanofi with a total value of $23,036,682.24 on March 25, 2014.
The single biggest insider sell for Alnylam Pharmaceuticals Inc was from Akshay Vaishnaw with a total value of $12,672,077.40 on March 14, 2018.